Patents by Inventor Fumiyoshi Okano
Fumiyoshi Okano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230190899Abstract: An object of the present invention is to discover a novel peptide useful as an active ingredient in an agent for treating or preventing cancer, and to provide the use of the polypeptide as an immune inducer. The immune inducer containing as an active ingredient: (a) a polypeptide consisting of any one of the amino acid sequences represented by SEQ ID NOs: 35 to 67; or (b) a polypeptide comprising one to several amino acid deletions, substitutions and/or additions in the amino acid sequence of the polypeptide (a); is useful as an agent for treating or preventing cancer, etc.Type: ApplicationFiled: October 24, 2022Publication date: June 22, 2023Applicant: TORAY INDUSTRIES, INC.Inventors: Akira KURIHARA, Fumiyoshi OKANO
-
Publication number: 20230165957Abstract: An object of the present invention is to provide a medicament for treatment and/or prevention of cancer. The present invention provides a medicament for treatment and/or prevention of cancer in a cancer patient with a previous history of another cancer treatment, comprising an antibody or a fragment thereof having an immunological reactivity with CAPRIN-1 protein, and a pyrimidine-based drug and cisplatin together or separately in combination.Type: ApplicationFiled: March 11, 2021Publication date: June 1, 2023Applicant: TORAY INDUSTRIES, INC.Inventors: Fumiyoshi OKANO, Daisuke AKAZAWA
-
Publication number: 20230159635Abstract: An object of the present invention is to provide a medicament for treatment and/or prevention of cancer. In order to attain the object, the present invention provides a medicament for treatment and/or prevention of cancer, comprising an antibody or a fragment thereof having an immunological reactivity with CAPRIN-1 protein, and an immune checkpoint inhibitor together or separately in combination.Type: ApplicationFiled: March 11, 2021Publication date: May 25, 2023Applicant: TORAY INDUSTRIES, INC.Inventor: Fumiyoshi OKANO
-
Publication number: 20230139178Abstract: An object of the present invention is to provide a medicament for treatment and/or prevention of cancer. The present invention provides a medicament for treatment and/or prevention of cancer, comprising an antibody or a fragment thereof having an immunological reactivity with CAPRIN-1 protein, and a pyrimidine fluoride-based drug, a folinic acid-based drug and one or more additional drugs together or separately in combination.Type: ApplicationFiled: March 11, 2021Publication date: May 4, 2023Applicant: TORAY INDUSTRIES, INC.Inventor: Fumiyoshi OKANO
-
Publication number: 20230140155Abstract: An object of the present invention is to provide a pharmaceutical composition for treatment and/or prevention of cancer. The present invention provides a medicament for treatment and/or prevention of cancer in a cancer patient with a previous history of another cancer treatment, comprising an antibody or a fragment thereof having an immunological reactivity with CAPRIN-1 protein, and a pyrimidine-based drug and carboplatin together or separately in combination.Type: ApplicationFiled: March 11, 2021Publication date: May 4, 2023Applicant: TORAY INDUSTRIES, INC.Inventor: Fumiyoshi OKANO
-
Publication number: 20230129035Abstract: An object of the preset invention is to provide a medicament for treatment and/or prevention of cancer. The present invention relates to a medicament for treatment and/or prevention of cancer in a cancer patient with a previous history of another cancer treatment, comprising an antibody or a fragment thereof haying an immunological reactivity with CAPRIN-1 protein, and an angiogenesis inhibitor or an angiogenesis inhibitor and a taxane-based drug together or separately in combination.Type: ApplicationFiled: March 11, 2021Publication date: April 27, 2023Applicant: TORAY INDUSTRIES, INC.Inventors: Fumiyoshi OKANO, Daisuke AKAZAWA
-
Publication number: 20230030982Abstract: An object of the present invention is to identify cancer antigen proteins specifically expressed on the surface of cancer cells and to provide a use of antibodies targeting such proteins as therapeutic and/or preventive agents for cancer. The present invention relates to, for example, a pharmaceutical composition for treatment and/or prevention of a cancer, which comprises, as an active ingredient, an antibody or fragment thereof having an immunological reactivity with an MCEMP1 protein having an amino acid sequence shown in any one of the even numbered SEQ ID NOS: 2 to 8 or an amino acid sequence having 80% or more sequence identity with the amino acid sequence, or with a fragment of the MCEMP1 protein comprising 7 or more consecutive amino acids.Type: ApplicationFiled: October 5, 2022Publication date: February 2, 2023Applicant: TORAY INDUSTRIES, INC.Inventors: Takayuki FUJITA, Fumiyoshi OKANO
-
Patent number: 11510971Abstract: An object of the present invention is to discover a novel peptide useful as an active ingredient in an agent for treating or preventing cancer, and to provide the use of the polypeptide as an immune inducer. The immune inducer contains as an active ingredient, the following (i) or (ii): (i) at least one polypeptide having an immune-inducing activity and selected from the group of polypeptides (a) or (b), where: (a) polypeptides consisting of 7 or more consecutive amino acids within the region of positions 24 to 97 in the amino acid sequence represented by SEQ ID NO: 2; and (b) polypeptides comprising one to several amino acid deletions, substitutions and/or additions in the amino acid sequence of any one of the polypeptides (a); and (ii) a recombinant vector comprising at least one polynucleotide encoding any one of the polypeptides, and capable of expressing the polypeptide in vivo.Type: GrantFiled: August 5, 2016Date of Patent: November 29, 2022Assignee: TORAY INDUSTRIES, INC.Inventors: Akira Kurihara, Fumiyoshi Okano
-
Patent number: 11492410Abstract: An object of the present invention is to identify cancer antigen proteins specifically expressed on the surface of cancer cells and to provide a use of antibodies targeting such proteins as therapeutic and/or preventive agents for cancer. The present invention relates to, for example, a pharmaceutical composition for treatment and/or prevention of a cancer, which comprises, as an active ingredient, an antibody or fragment thereof having an immunological reactivity with an MCEMP1 protein having an amino acid sequence shown in any one of the even numbered SEQ ID NOS: 2 to 8 or an amino acid sequence having 80% or more sequence identity with the amino acid sequence, or with a fragment of the MCEMP1 protein comprising 7 or more consecutive amino acids.Type: GrantFiled: March 27, 2017Date of Patent: November 8, 2022Assignee: Toray Industries, Inc.Inventors: Takayuki Fujita, Fumiyoshi Okano
-
Patent number: 11478539Abstract: This application provides an immunity-inducing agent comprising, as an active ingredient, at least one polypeptide having immunity-inducing activity and selected from (a) polypeptides consisting of amino acid sequences represented by SEQ ID NO: 8, 4, 6, 10, 12, 2 and 14, and polypeptides consisting of 7 or more consecutive amino acids in the amino acid sequences, (b) polypeptides having a sequence identity of 85% or more with the amino acid sequences represented by SEQ ID NO: 8, 4, 6, 10, 12, 2 and 14, and polypeptides consisting of 7 or more consecutive amino acids in the amino acid sequences, and (c) polypeptides comprising the polypeptides according to (a) or (b) as the partial sequences, or a recombinant vector comprising a polynucleotide encoding the polypeptide and capable of expressing the polypeptide in vivo.Type: GrantFiled: January 17, 2020Date of Patent: October 25, 2022Assignee: Toray Industries, Inc.Inventors: Akira Kurihara, Fumiyoshi Okano
-
Patent number: 11318185Abstract: The present invention addresses the problem of finding a novel peptide useful as an active ingredient in an agent for treating or preventing cancer, and to provide the use of the polypeptide as an immune inducer. The immune inducer containing as an active ingredient: (a) a polypeptide consisting of any one of the amino acid sequences represented by SEQ ID NOs: 3 to 45; or (b) a polypeptide comprising one to several amino acid deletions, substitutions or additions in the amino acid sequence of the polypeptide (a); is useful as an agent for treating or preventing cancer, etc.Type: GrantFiled: March 1, 2017Date of Patent: May 3, 2022Assignee: TORAY INDUSTRIES, INC.Inventors: Akira Kurihara, Fumiyoshi Okano
-
Patent number: 11224625Abstract: The present invention relates to a novel immunity-inducing agent for treatment and/or prevention of cancer. Specifically, the present invention relates to an immunity-inducing agent comprising, as an active ingredient, at least one polypeptide having immunity-inducing activity and selected from polypeptides derived from MRAP2 and modified forms thereof, or a recombinant vector comprising a polynucleotide encoding the polypeptide and capable of expressing the polypeptide in vivo, and a method for inducing immunity, comprising administering the immunity-inducing agent to a subject.Type: GrantFiled: March 27, 2017Date of Patent: January 18, 2022Assignee: TORAY INDUSTRIES, INC.Inventors: Takayuki Fujita, Fumiyoshi Okano
-
Patent number: 11137401Abstract: The present invention relates to a method for detecting cancer, comprising measuring the expression of a polypeptide having a reactivity of binding to an antibody against a CAPRIN-1 protein having an amino acid sequence shown in any one of the even-numbered SEQ ID NOS: 2-30 in the Sequence Listing via an antigen-antibody reaction in a sample separated from a living organism, and, a reagent for detecting a cancer comprising the CAPRIN-1 protein or a fragment thereof, an antibody against the CAPRIN-1 protein or a fragment thereof, or a polynucleotide encoding the CAPRIN-1 protein or a fragment thereof.Type: GrantFiled: August 5, 2009Date of Patent: October 5, 2021Assignee: TORAY INDUSTRIES, INC.Inventors: Fumiyoshi Okano, Kana Suzuki
-
Patent number: 11129893Abstract: An object of the present invention is to identify a cancer antigen protein specifically expressed on the surface of cancer cells and provide use of an antibody targeting the cancer antigen protein as a therapeutic and/or prophylactic agent for cancer. A pharmaceutical composition for treating and/or preventing cancer comprising an antibody or a fragment thereof having immunological reactivity with CSPG5 protein consisting of any one of amino acid sequences represented by SEQ ID NOs: 8, 4, 6, 10, and 12 and an amino acid sequence having an amino acid identity of 80% or more to the amino acid sequence, or a fragment thereof consisting of 7 or more consecutive amino acids, as an active ingredient.Type: GrantFiled: April 28, 2016Date of Patent: September 28, 2021Assignee: TORAY INDUSTRIES, INC.Inventors: Akira Kurihara, Hyongi Chon, Takayuki Fujita, Fumiyoshi Okano
-
Patent number: 11045534Abstract: The present application relates to a novel immunity-inducing agent for treatment and/or prevention of cancer. Specifically, the present application provides an immunity-inducing agent comprising, as an active ingredient, at least one polypeptide having immunity-inducing activity and selected from polypeptides derived from MCEMP1 and modified forms thereof, or a recombinant vector comprising a polynucleotide encoding the polypeptide and capable of expressing the polypeptide in vivo, and a method for inducing immunity, comprising administering the immunity-inducing agent to a subject.Type: GrantFiled: March 27, 2017Date of Patent: June 29, 2021Assignee: TORAY INDUSTRIES, INC.Inventors: Takayuki Fujita, Fumiyoshi Okano
-
Publication number: 20210188998Abstract: The present invention relates to a pharmaceutical composition for treatment and/or prevention of cancer, which comprises, as an active ingredient, an antibody or fragment thereof having an immunological reactivity with a CAPRIN-1 protein or a fragment thereof comprising 7 or more consecutive amino acids.Type: ApplicationFiled: February 17, 2021Publication date: June 24, 2021Applicant: TORAY INDUSTRIES, INC.Inventors: Fumiyoshi OKANO, Takayoshi IDO, Takanori SAITO, Shinichi KOBAYASHI
-
Publication number: 20210121562Abstract: A medicament for treatment and/or prevention of cancer, comprising an antibody or a fragment thereof having an immunological reactivity with a CAPRIN-1 protein, and imiquimod together or separately in combination can treat and/or prevent cancer specifically expressing CAPRIN-1 protein on a cell surface.Type: ApplicationFiled: March 29, 2019Publication date: April 29, 2021Applicant: TORAY INDUSTRIES, INC.Inventors: Fumiyoshi OKANO, Takanori SAITO
-
Publication number: 20200247888Abstract: An antibody or a fragment thereof having immunoreactivity to a polypeptide comprising not less than 7 continuous amino acids in the CD179b protein, which was identified as a cancer antigen protein specifically expressed on the surfaces of cancer cells, can be used as a pharmaceutical composition for therapy and/or prophylaxis of cancer.Type: ApplicationFiled: February 25, 2020Publication date: August 6, 2020Inventors: Fumiyoshi OKANO, Takanori SAITO, Takayoshi IDO, Masaki SHIMIZU
-
Publication number: 20200138926Abstract: This application provides an immunity-inducing agent comprising, as an active ingredient, at least one polypeptide having immunity-inducing activity and selected from (a) polypeptides consisting of amino acid sequences represented by SEQ ID NO: 8, 4, 6, 10, 12, 2 and 14, and polypeptides consisting of 7 or more consecutive amino acids in the amino acid sequences, (b) polypeptides having a sequence identity of 85% or more with the amino acid sequences represented by SEQ ID NO: 8, 4, 6, 10, 12, 2 and 14, and polypeptides consisting of 7 or more consecutive amino acids in the amino acid sequences, and (c) polypeptides comprising the polypeptides according to (a) or (b) as the partial sequences, or a recombinant vector comprising a polynucleotide encoding the polypeptide and capable of expressing the polypeptide in vivo.Type: ApplicationFiled: January 17, 2020Publication date: May 7, 2020Applicant: TORAY INDUSTRIES, INC.Inventors: Akira KURIHARA, Fumiyoshi OKANO
-
Patent number: 10611835Abstract: An antibody or a fragment thereof having immunoreactivity to a polypeptide comprising not less than 7 continuous amino acids in the CD179b protein, which was identified as a cancer antigen protein specifically expressed on the surfaces of cancer cells, can be used as a pharmaceutical composition for therapy and/or prophylaxis of cancer.Type: GrantFiled: July 10, 2009Date of Patent: April 7, 2020Assignee: Toray Industries, Inc.Inventors: Fumiyoshi Okano, Takanori Saito, Takayoshi Ido, Masaki Shimizu